Trials / Completed
CompletedNCT01364623
PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women
An Open-label, Single and Multiple Application of Intranasal Testosterone Gel (TBS-2) in Healthy Premenopausal Female Subjects at Three Dose Levels
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Acerus Pharmaceuticals Corporation · Industry
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study was to assess the bioavailability of total testosterone through pharmacokinetic profiles obtained following (a) single administration of three doses of TBS-2 b) multiple administration TBS-2. In addition, assessing the bioavailability of free testosterone, dihydrotestosterone, SHBG and estradiol through pharmacokinetic profiles was also conducted.
Detailed description
This is a 2 Period study that requires overnight stays in clinic. Blood samples are required at all visits including sampling at predefined time periods during the overnight stays. Period I Subjects were checked-in on Day 1 Period I to start their baseline testosterone measurement (dependant on menstrual cycle, preferably within 48hr of start of the menstrual cycle). They remained institutionalized until Day 4 morning, and were checked out after the 48 hour blood draw and study close-out for those that did not continue with Period II. Period II (Multi-Dose) At the end of Period 1, a total of 8 subjects sampled from these 3 cohorts, who were willing and able to continue with the multiple-dose portion of the study were selected to participate in Period 2. Subjects were institutionalized starting on Day 1 of Visit 3 until Day 5 morning of Visit 3, and were checked out after the 48 hour blood draw and study close-out.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Low dose testosterone nasal gel, single dose | Low dose testosterone nasal gel, single dose |
| DRUG | Medium dose testosterone nasal gel, single dose | Medium dose testosterone nasal gel, single dose |
| DRUG | High dose testosterone nasal gel, single dose | High dose testosterone nasal gel, single dose |
| DRUG | Medium dose testosterone nasal gel, multiple dose | Medium dose testosterone nasal gel, multiple dose |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2012-01-01
- Completion
- 2012-02-01
- First posted
- 2011-06-02
- Last updated
- 2019-10-16
- Results posted
- 2019-09-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01364623. Inclusion in this directory is not an endorsement.